These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 29026473)

  • 21. [Efficacy of pegylated interferon alpha-2a and ribavirin treatment in chronic hepatitis C patients depends on various baseline parameters and early viral kinetics].
    Husa P; Slesinger P; Stroblová H; Svobodník A; Husová L
    Klin Mikrobiol Infekc Lek; 2008 Apr; 14(2):67-73. PubMed ID: 18756436
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The incidence of viremia and the heterogeneity of hepatitis C virus genotypes among blood donors, hemophiliacs and patients with chronic liver disease.
    Kuperan P; Aw TC; Ishiko H; Hashimoto O; Takeda N
    Pathology; 1996 Nov; 28(4):348-51. PubMed ID: 9007955
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Atorvastatin in Combination with Pegylated Interferon and Ribavirin Provided High Rate of Sustained Virological Response in Patients with Genotype 3 Hepatitis C Virus.
    Todorovska B; Caloska-Ivanova V; Dimitrova-Genadieva M; Trajkovska M; Popova-Jovanovska R; Grivceva-Stardelova K; Licoska-Josifovic F; Andreevski V; Curakova-Ristovska E; Joksimovic N
    Open Access Maced J Med Sci; 2019 May; 7(10):1641-1648. PubMed ID: 31210815
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Response to combined interferon and ribavirin is better in patients infected with hepatitis C virus genotype 6 than genotype 1 in Hong Kong.
    Yuen MF; Lai CL
    Intervirology; 2006; 49(1-2):96-8. PubMed ID: 16166796
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distribution pattern of hepatitis C virus genotypes and correlation with viral load and risk factors in chronic positive patients.
    Petruzziello A; Coppola N; Loquercio G; Marigliano S; Giordano M; Azzaro R; Diodato AM; Iervolino V; Di Costanzo G; Di Macchia CA; Di Meo T; Paradiso L; Ferro R; Giuliano P; Russo F; Pasquale G; Cacciapuoti C
    Intervirology; 2014; 57(6):311-8. PubMed ID: 25170801
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatitis C virus genotypes in the United States: epidemiology, pathogenicity, and response to interferon therapy. Collaborative Study Group.
    Zein NN; Rakela J; Krawitt EL; Reddy KR; Tominaga T; Persing DH
    Ann Intern Med; 1996 Oct; 125(8):634-9. PubMed ID: 8849147
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Appendix: The National Institutes of Health Consensus Development Conference Management of Hepatitis C 2002.
    Seeff LB; Hoofnagle JH
    Clin Liver Dis; 2003 Feb; 7(1):261-87. PubMed ID: 12691470
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular epidemiology of HCV infection among acute and chronic liver disease patients in Kolkata, India.
    Chaudhuri S; Das S; Chowdhury A; Santra A; Bhattacharya SK; Naik TN
    J Clin Virol; 2005 Jan; 32(1):38-46. PubMed ID: 15572005
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phylogenetic analysis of hepatitis C virus isolates and their correlation to viremia, liver function tests, and histology.
    Zeuzem S; Franke A; Lee JH; Herrmann G; Ruster B; Roth WK
    Hepatology; 1996 Nov; 24(5):1003-9. PubMed ID: 8903367
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Chronic hepatitis C virus infection: is there a correlation between HCV genotypes and the level of viremia?].
    Delić D; Nesić Z; Simonović J; Svirtlih N; Dokić L; Nesković G
    Med Pregl; 2006; 59(5-6):230-4. PubMed ID: 17039904
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Review article: the epidemiology and therapy of chronic hepatitis C genotypes 4, 5 and 6.
    Wantuck JM; Ahmed A; Nguyen MH
    Aliment Pharmacol Ther; 2014 Jan; 39(2):137-47. PubMed ID: 24251930
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic polymorphisms of ICAM 1 and IL28 as predictors of liver fibrosis severity and viral clearance in hepatitis C genotype 4.
    Rizk NM; Derbala MF
    Clin Res Hepatol Gastroenterol; 2013 Jun; 37(3):262-8. PubMed ID: 23137758
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictors of liver fibrosis in HIV-infected patients with chronic hepatitis C virus (HCV) infection: assessment using transient elastometry and the role of HCV genotype 3.
    Barreiro P; Martín-Carbonero L; Núñez M; Rivas P; Morente A; Simarro N; Labarga P; González-Lahoz J; Soriano V
    Clin Infect Dis; 2006 Apr; 42(7):1032-9. PubMed ID: 16511772
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genotype distribution in relation to viral load in a large cohort of Indian patients with chronic hepatitis C virus infection: A retrospective analysis.
    Panyala BR; Mukherjee RM; Devarakonda H; Tadivaka S; Padaki NR; Sharma M; Duvvuru NR
    Indian J Gastroenterol; 2019 Apr; 38(2):110-116. PubMed ID: 30903612
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IL15 polymorphism is associated with advanced fibrosis, inflammation-related biomarkers and virological response in human immunodeficiency virus/hepatitis C virus coinfection.
    Jiménez-Sousa MA; Berenguer J; Rallón N; Pineda-Tenor D; Aldamiz-Echevarria T; Soriano V; García-Álvarez M; Vazquez-Morón S; Restrepo C; Carrero A; Benito JM; Resino S
    Liver Int; 2016 Sep; 36(9):1258-66. PubMed ID: 26836972
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Responder Interferon λ Genotypes Are Associated With Higher Risk of Liver Fibrosis in HIV-Hepatitis C Virus Coinfection.
    Moqueet N; Cooper C; Gill J; Hull M; Platt RW; Klein MB;
    J Infect Dis; 2016 Jul; 214(1):80-6. PubMed ID: 26984148
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiviral regimen complexity index as an independent predictor of sustained virologic response in patients with chronic hepatitis C.
    Galán RJ; Cidoncha EC; Martin MF; Rodriguez CC; Almeida CV; Verdugo RM
    J Manag Care Pharm; 2013; 19(6):448-53. PubMed ID: 23806058
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis C virus genotyping in Greece: unexpected high prevalence of genotype 5a in a Greek island.
    Karatapanis S; Tsoplou P; Papastergiou V; Vasiageorgi A; Stampori M; Saitis I; Tsitsopoulos E; Lisgos P; Skorda L; Ketikoglou I; Goulis I
    J Med Virol; 2012 Feb; 84(2):223-8. PubMed ID: 22170541
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early on-treatment viral load and baseline METAVIR score: improved prediction of sustained virological response in HCV genotype 1 patients.
    Crawford DH; Dore GJ; Sievert W; Cheng WS; Weltman M; McCaughan G; Rawlinson W; Marks PS; Yoshihara M; Rizkalla B; Roberts SK;
    Antivir Ther; 2012; 17(5):849-54. PubMed ID: 22513456
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A European single centre experience of management of hepatitis C virus genotype 4 infection with pegylated-interferon and ribavirin.
    Selvapatt N; Habibi MS; Brown A
    J Med Virol; 2015 Oct; 87(10):1716-21. PubMed ID: 25914248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.